MedTrace Logo

Burst Optimized Stimulation Study

NCT02896361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2019-05-30

Study results available
· View outcomes & findings →

Summary

This purpose of this study is to evaluate the therapeutic efficacy of burst microdosing stimulation paradigms in patients with chronic pain.

Conditions

Interventions

DEVICE

Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol

Stimulation parameters are reprogrammed from original values to study defined ones

Sponsors & Collaborators

  • Medizinische Einrichtungen der Universität Düsseldorf

    collaborator UNKNOWN

  • Klinikum Duisburg GmbH

    collaborator UNKNOWN

  • NKO Sint-Augustinus Antwerpen

    collaborator UNKNOWN

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Lalit Venkatesan, Ph.D. · Abbott Medical Devices

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Belgium
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02896361 on ClinicalTrials.gov